Düsseldorf, June 13, 2007—Shearman & Sterling advised Droege International Group AG on the sale of the pharmaceutical business of Madaus Group to Rottapharm, Italy.  The buyer will also acquire the shares currently remaining in possession of the Madaus family.

The transaction is subject to approval by the relevant antitrust authorities.

Droege International Group AG and the Madaus family will in particular keep the activities in the allergy sector and the shares in Servox AG, which is active in the fields of home-care.

Shearman & Sterling attorneys Harald Selzner (partner, M&A, Düsseldorf), Johannes Frey (partner, Tax, Frankfurt), Hans Jürgen Meyer-Lindemann (partner, Antitrust, Düsseldorf), Martin Neuhaus (associate, M&A, Düsseldorf/Mannheim), Christoph Neven (associate, M&A, Düsseldorf), Bodo Bender (associate, Tax, Frankfurt) and Alexander Remplik (associate, Tax, Düsseldorf) advised the family managed Droege International Group AG on this transaction.  The same team was active in the restructuring of Madaus in the year 2004 on the sale of Wasserburger Arzneimittelwerk Dr. Madaus GmbH.